Analyte measured to Lymecycline bioequivalence study [Bioanalytics]

posted by Mauricio Sampaio  – Brazil, 2013-09-02 17:50 (4285 d 02:37 ago) – Posting: # 11409
Views: 9,061

Dear,

in Public Assessment Report of Lymecycline 408 capsules from MHRA (UK/H/1889/002/DC)* the pharmacokinetics results of bioequivalence study of Lymecycline is based on data from Tetracycline and not Lymecycline (page 13). However, in page 10, the Lymecycline is described as active substance.

In this case Lymecycline is a prodrug and serves as a type of precursor to the intended drug (Tetracycline)?

Please, clarify my doubt.

* http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con205367.pdf

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
56 visitors (0 registered, 56 guests [including 12 identified bots]).
Forum time: 20:27 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5